Merck ends improvement of two antibody packages
JHVEPhoto/iStock Editorial through Getty Photographs Merck (NYSE:MRK) is ceasing improvement of two monoclonal antibody candidates it was eying as fixed-doses ...
JHVEPhoto/iStock Editorial through Getty Photographs Merck (NYSE:MRK) is ceasing improvement of two monoclonal antibody candidates it was eying as fixed-doses ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.